Results 211 to 220 of about 365,679 (259)

Prognostic value of heart rate variability for risk of serious adverse events in continuously monitored hospital patients. [PDF]

J Clin Monit Comput
Aagaard N, Olsen MH, Rasmussen OW, Grønbaek KK, Mølgaard J, Haahr-Raunkjaer C, Elvekjaer M, Aasvang EK, Meyhoff CS.   +8 more
europepmc   +1 more source

Predicting serious adverse events or a safety net - Rethinking the role of early warning scores. [PDF]

Resusc Plus
Haegdorens F.
europepmc   +1 more source

Correction to "Depression and anxiety in cancer patient enrolled in clinical trials with serious adverse events". [PDF]

Cancer Med
europepmc   +1 more source

Adverse Events (AE) and Serious Adverse Events (SAE) Reporting

openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The International Serious Adverse Events Consortium

Nature Reviews Drug Discovery, 2014
The International Serious Adverse Events Consortium is generating novel insights into the genetics and biology of drug-induced serious adverse events, and thereby improving pharmaceutical product development and decision-making.
Jorge Contreras, , Sally John
exaly   +3 more sources

Remimazolam and serious adverse events

European Journal of Anaesthesiology, 2023
Remimazolam is anticipated to be an interesting anaesthetic and sedative. It combines the pharmacodynamic properties of midazolam with pharmacokinetic properties similar to remifentanil. However, worrisome case reports of anaphylaxis, delayed emergence and re-sedation have emerged recently and necessitate further investigation.
Sander, Kempenaers, Tom G, Hansen, Marc, Van de Velde   +2 more
openaire   +2 more sources

Rates of adverse and serious adverse events in children with cystic fibrosis

Journal of Cystic Fibrosis, 2021
Cystic fibrosis (CF) is an autosomal recessive disease characterized by chronic sinopulmonary symptoms and chronic gastrointestinal symptoms that begins in infancy. Children with CF are increasingly being included in clinical trials. In order to fully evaluate the impact of new therapies in future clinical trials, an understanding of baseline adverse ...
Jessica E. Pittman, Umer Khan, Theresa A. Laguna, Sonya Heltshe, Christopher H. Goss, Don B. Sanders   +5 more
openaire   +2 more sources

Serious Adverse Events With Infliximab: Analysis of Spontaneously Reported Adverse Events

Clinical Gastroenterology and Hepatology, 2007
Serious adverse events such as bowel obstruction, heart failure, infection, lymphoma, and neuropathy have been reported with infliximab. The aims of this study were to explore adverse event signals with infliximab by using a long period of post-marketing experience, stratifying by indication.The relative reporting of infliximab adverse events to the U ...
Richard A, Hansen, Gerald, Gartlehner, Gregory E, Powell, Robert S, Sandler   +3 more
openaire   +2 more sources